Asynchrony in Operated Tetralogy of Fallot

Status Not yet recruiting

Clinical Trial Summary

The objective of this work is to estimate the correlation between the electrical activation of the VD measured by the CARTO electrophysiological mapping system and the mechanical activation of the VD measured by 3D echocardiography and 3D speckle-tracking. Our hypothesis is that there is a strong correlation between electrical activation and mechanical activation in patients with an operated Fallot tetralogy.

Clinical Trial Description

Fallot tetralogy is the most common cyanogenic congenital heart disease. Thanks to advances in surgery, most patients survive to adulthood but develop a failure of the function of the right ventricle and then of the left ventricle resulting in progressive heart failure and death of patients. Despite corrective surgeries in adulthood, including pulmonary valve surgery, heart failure remains a major problem. One of the mechanisms of this heart failure is the right intraventtricular asynchronism associated with the postoperative right branch block, which will secondaryly become complicated from an interventricular asynchronism for left intraventtricular, partly explaining the overall progressive failure of cardiac function. To date, there is no model for combining a combined analysis of electrical and mechanical activation in the same patients. Understanding these mechanisms would allow us to better understand the pathophysiology of heart failure in this population and to propose targeted therapies to prevent this asynchronism by adapting surgical techniques, or treating this asynchronism with electrical therapy such as bivascular resynchronization. Each patient in each group will perform, according to standard practice, an electrophysiological exploration with mapping of the heart using the CARTO system, a cardiac MRI and a 3-dimensional transthoracic echocardiography. The follow-up of each patient takes place during a scheduled hospitalization as part of the care. Their participation in the study only lasts for the duration of the hospitalization. ;

Study Design

Related Conditions & MeSH terms

Tetralogy of Fallot

Clinical Trial Details

NCT number	NCT05485545
Study type	Interventional
Source	University Hospital, Bordeaux
Contact	Xavier IRART, MD
Phone	(0)5 57 65 64 65
Email	xavier.iriart@chu-bordeaux.fr
Status	Not yet recruiting
Phase	N/A
Start date	September 1, 2022
Completion date	September 1, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02534792` - Early Revalvulation After Fallot Repair Improves Clinical Outcome	N/A
Completed	`NCT00536432` - Early Re-intervention in Infants and Small Children After Correction of Tetralogy of Fallot	N/A
Completed	`NCT01941576` - Effects of rhBNP in Pediatrics After Corrective Repair of Tetralogy Of Fallot	N/A
Active, not recruiting	`NCT03983512` - PULSTA Transcatheter Pulmonary Valve Pre-Approval Study	N/A
Recruiting	`NCT04581668` - Impact of NAVA Ventilation on Brain Oxygenation and Perfusion in Children With Congenital Heart Disease	N/A
Completed	`NCT01762124` - Study of the Native Outflow Tract Transcatheter Pulmonary Valve (TPV)	N/A
Active, not recruiting	`NCT02161471` - Haemodynamics and Function of the Atria in Congenital Heart Disease by Cardiovascular Magnetic Resonance
Not yet recruiting	`NCT05916976` - Repaired Tetralogy of Fallot: Risc Score From MRI & Clinical Data to Predict the Need for Change of Treatment	N/A
Recruiting	`NCT04106479` - NIRS in Congenital Heart Defects - Correlation With Echocardiography
Completed	`NCT05579964` - The Role of Dexmedetomidine as Myocardial Protector in Pediatric Cardiac Surgery Total Correction of Tetralogy of Fallot	Phase 2/Phase 3
Recruiting	`NCT05236153` - Electroanatomic Interactions Between Transcatheter Pulmonary Valve Prostheses and Anatomic Isthmuses in Repaired Tetralogy of Fallot	N/A
Recruiting	`NCT03049995` - Stress Echo 2020 - The International Stress Echo Study
Completed	`NCT02586740` - Retrospective Review of Anesthetic Considerations for Pulmonary Artery Rehabilitation	N/A
Terminated	`NCT00564993` - Cardiac Function Under Stress for Early Detection of the Right Ventricular Insufficiency After Repair of Tetralogy of Fallot	Phase 3
Recruiting	`NCT05122962` - Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot and Other Congenital Heart Diseases
Completed	`NCT06097377` - Lymphatic Magnetic Resonance Imaging Abnormalities in Children With Tetralogy of Fallot: A Case-Control Study
Completed	`NCT03835494` - Analysis of RV-Dysfunction in Fallot Patients	N/A
Not yet recruiting	`NCT03275844` - Physical Capacity and Activity in Children With Congenital Heart Disease	N/A
Recruiting	`NCT02590679` - Multi-center Trial of Percutaneous Pulmonary Valve Implantation With Venus-p	Phase 2/Phase 3
Recruiting	`NCT00155428` - Biomodel in Tetralogy of Fallot	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Asynchrony in Operated Tetralogy of Fallot — FALLOT-XI

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms